Serevent and Mycelex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Serevent (salmeterol xinafoate) and Mycelex (clotrimazole). Common drug interactions include hypotension among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Serevent and Mycelex. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Serevent?

Serevent has active ingredients of salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 15,586 Serevent users. Check the latest studies of Serevent.

What is Mycelex?

Mycelex has active ingredients of clotrimazole. eHealthMe is studying from 1,876 Mycelex users. Check the latest studies of Mycelex.



On Aug, 09, 2026

27 people who take Serevent and Mycelex together, and have interactions are studied.

Serevent and Mycelex drug interactions.

What are the common drug interactions of Serevent and Mycelex, by gender? *:

female:

  1. Hypotension (abnormally low blood pressure)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Migraine (headache)
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Oesophageal reflux (moving the food downwards)
  6. Pneumoperitoneum (air or gas in the abdominal (peritoneal) cavity)
  7. Productive cough
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Rhinitis allergic (inflammation of the nasal airways due to allergy)
  10. Septic shock (shock due to blood infection)

male:

  1. Fatigue (feeling of tiredness)
  2. Pneumonia
  3. Dehydration (dryness resulting from the removal of water)
  4. Delusional disorder, unspecified type
  5. Depression
  6. Diarrhoea
  7. Drug dependence
  8. Drug tolerance increased
  9. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  10. Dysphonia (speech disorder attributable to a disorder of phonation)

What are the common drug interactions of Serevent and Mycelex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
  2. Respiratory failure (excl neonatal) (inadequate gas exchange by the respiratory system(excluding neonatal))
  3. Pneumonia
  4. Pneumonia legionella (pneumonia caused by the bacteria legionella)

20-29:

n/a

30-39:

  1. Pyelonephritis (inflammation of kidney caused by bacteria)
  2. Weakness
  3. Abdominal pain
  4. Autoimmune hepatitis
  5. Cholecystitis (infection of gallbladder)
  6. Fatigue (feeling of tiredness)
  7. Hepatitis (inflammation of the liver)
  8. Hepatomegaly (abnormal enlargement of the liver)
  9. Nausea (feeling of having an urge to vomit)
  10. Pyrexia (fever)

40-49:

n/a

50-59:

  1. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  2. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  3. Haematuria (presence of blood in urine)
  4. Headache (pain in head)
  5. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  6. Hypercholesterolaemia (high levels of cholesterol in the blood)
  7. Hypokalaemia (low potassium)
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  9. Hypoxia (low oxygen in tissues)
  10. Intertrigo candida (infection of the skin by candida albicans)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Abdominal discomfort
  3. Delusional disorder, unspecified type
  4. Depression
  5. Diarrhoea
  6. Drug dependence
  7. Drug tolerance increased
  8. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  9. Dysphonia (speech disorder attributable to a disorder of phonation)
  10. Dysuria (painful or difficult urination)

What are the existing conditions these people have? *

  1. Pain: 5 people, 18.52%
  2. Depression: 4 people, 14.81%

* Approximation only. Some reports may have incomplete information.

Do you take Serevent and Mycelex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Serevent and Mycelex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Serevent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mycelex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Serevent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mycelex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on salmeterol xinafoate and clotrimazole (the active ingredients of Serevent and Mycelex, respectively), and Serevent and Mycelex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: